SynthesisFrontiers in endocrinology2024

First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis.

Rui Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.